The Pathogenesis of Gastrointestinal, Hepatic, and Pancreatic Injury in Acute and Long Coronavirus Disease 2019 Infection.


Journal

Gastroenterology clinics of North America
ISSN: 1558-1942
Titre abrégé: Gastroenterol Clin North Am
Pays: United States
ID NLM: 8706257

Informations de publication

Date de publication:
03 2023
Historique:
entrez: 22 2 2023
pubmed: 23 2 2023
medline: 25 2 2023
Statut: ppublish

Résumé

The gastrointestinal (GI) tract is targeted by severe acute respiratory syndrome coronavirus-2. The present review examines GI involvement in patients with long coronavirus disease and discusses the underlying pathophysiological mechanisms that include viral persistence, mucosal and systemic immune dysregulation, microbial dysbiosis, insulin resistance, and metabolic abnormalities. Due to the complex and potentially multifactorial nature of this syndrome, rigorous clinical definitions and pathophysiology-based therapeutic approaches are warranted.

Identifiants

pubmed: 36813418
pii: S0889-8553(22)00091-7
doi: 10.1016/j.gtc.2022.12.001
pmc: PMC9721275
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

Gastroenterology. 2020 Sep;159(3):1137-1140.e2
pubmed: 32389667
Cell. 2021 Feb 4;184(3):775-791.e14
pubmed: 33503446
Neurogastroenterol Motil. 2022 Mar;34(3):e14251
pubmed: 34468069
Nat Metab. 2022 Mar;4(3):310-319
pubmed: 35347318
Lancet Respir Med. 2022 Jul;10(7):632-634
pubmed: 35525253
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678
pubmed: 32405603
Cell. 2020 Jan 9;180(1):33-49.e22
pubmed: 31813624
Science. 2022 Mar 11;375(6585):1122-1127
pubmed: 35271343
Gastroenterology. 2020 Jul;159(1):320-334.e27
pubmed: 32407808
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Front Endocrinol (Lausanne). 2020 Dec 14;11:597648
pubmed: 33384662
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Cell. 2021 Nov 11;184(23):5715-5727.e12
pubmed: 34717799
Front Endocrinol (Lausanne). 2020 Nov 13;11:596898
pubmed: 33281748
J Clin Med. 2022 Sep 14;11(18):
pubmed: 36143044
Nat Rev Gastroenterol Hepatol. 2022 Jun;19(6):345-346
pubmed: 35383321
Gut. 2022 Mar;71(3):544-552
pubmed: 35082169
Emerg Microbes Infect. 2022 Dec;11(1):1115-1125
pubmed: 35343389
Cell. 2020 May 14;181(4):914-921.e10
pubmed: 32330414
Front Med (Lausanne). 2020 Nov 11;7:608259
pubmed: 33262996
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Int J Environ Res Public Health. 2022 Aug 17;19(16):
pubmed: 36011823
Gastroenterology. 2022 Feb;162(2):648-650.e2
pubmed: 34728186
Nature. 2021 Jun;594(7862):259-264
pubmed: 33887749
Medicina (Kaunas). 2022 May 06;58(5):
pubmed: 35630058
Nat Metab. 2020 Dec;2(12):1391-1400
pubmed: 33244168
Front Immunol. 2022 Sep 05;13:939989
pubmed: 36131932
Gastroenterology. 2020 Aug;159(2):765-767.e2
pubmed: 32333911
Gastroenterology. 2021 Jun;160(7):2435-2450.e34
pubmed: 33676971
Front Physiol. 2021 May 11;12:667024
pubmed: 34045976
Signal Transduct Target Ther. 2022 Apr 29;7(1):143
pubmed: 35487886
Gastroenterology. 2020 Jul;159(1):81-95
pubmed: 32251668
Gastroenterology. 2022 Aug;163(2):495-506.e8
pubmed: 35508284
Nat Immunol. 2022 Feb;23(2):194-202
pubmed: 35105985
Biomedicines. 2022 Feb 23;10(3):
pubmed: 35327326
Front Cell Infect Microbiol. 2021 Jun 23;11:678482
pubmed: 34282405
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
J Clin Med. 2020 Jun 04;9(6):
pubmed: 32512688
Cell. 2022 Mar 3;185(5):881-895.e20
pubmed: 35216672
Nature. 2023 Nov;623(7985):139-148
pubmed: 37748514
Nat Immunol. 2022 Feb;23(2):210-216
pubmed: 35027728
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Gastroenterology. 2021 Jan;160(1):287-301.e20
pubmed: 32980345
Nat Immunol. 2022 Feb;23(2):165-176
pubmed: 35105981
Front Cell Infect Microbiol. 2022 Jun 30;12:922422
pubmed: 35846757
Nat Commun. 2021 Jun 10;12(1):3534
pubmed: 34112801
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Nat Metab. 2021 Feb;3(2):149-165
pubmed: 33536639
Nat Commun. 2022 Jan 25;13(1):446
pubmed: 35078982
Mucosal Immunol. 2019 Jul;12(4):843-850
pubmed: 30976087

Auteurs

Hadar Meringer (H)

Henry D. Janowitz Division of Gastroenterology, Department of Medicine; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 11-02, New York, NY 10029, USA.

Andrew Wang (A)

Henry D. Janowitz Division of Gastroenterology, Department of Medicine; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 11-02, New York, NY 10029, USA.

Saurabh Mehandru (S)

Henry D. Janowitz Division of Gastroenterology, Department of Medicine; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Icahn Building 11-02, New York, NY 10029, USA. Electronic address: saurabh.mehandru@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH